SK Plasma Invests 35.2 Billion KRW in Indonesian Subsidiary
SK Discovery, a KOSPI-listed company, announced on the 14th that its subsidiary SK Plasma will invest approximately 35.2 billion KRW in an Indonesian pharmaceutical manufacturing affiliate (PT. SKPLASMA CORE INDONESIA).
After the investment, the equity stake will be 29.6%.
Hot Picks Today
"We'll Pay 100% of Bonuses in Stock, Not Cash"...Employees Voting at This Company
- "Losing Jobs and Selling Bean Sprouts: Why They Left a Job Earning 6.76 Million Won per Month"
- "How Much Further Can It Fall?" Balances Fluctuate as KOSPI Drops 5% After Two Days of Gains
- Cardiac Arrests Surge in 40-Degree Heatwave, Hospitals Overwhelmed... Paris Issues Emergency "No Drinking" Ban
- "‘Hong Myungbo Banned from Entry’ Posted on Convenience Store Door... Headquarters Investigating Store Location"
SK Discovery explained the purpose of this investment as "additional equity investment for the establishment and leading operation of a local blood product factory."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
